glp 1 hepatic steatosis Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials GLP-1_receptor_som_behandling_af_steatotisk_leversygdom - SDU

If the inflammation is coming from an autoimmune condition, active infection, untreated sleep apnea, heavy alcohol use, or another non-metabolic cause, the effect may be modest or incomplete

So we looked beneath the surface of all-cause pancreatitis, at pancreatitis by specific cause.When we separated pancreatitis by cause, two opposing signals emerged: Increased risk of drug-induced pancreatitis: Reduced risks of alcohol-induced pancreatitis and triglyceride-induced pancreatitis These opposing forces cancelled each other out.This is why prior studies that lumped all pancreatitis together kept coming back null

LDN is most often considered in patients with refractory, multisystem presentations where broader neuroimmune or immunomodulatory strategies are being explored

Withhold fluid and food until sedation wears off